ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,576,014 | +208.5% | 43,887 | +144.5% | 0.01% | +233.3% |
| Q2 2023 | $6,994,535 | +21.3% | 17,947 | +15.9% | 0.00% | 0.0% |
| Q1 2023 | $5,768,466 | +0.3% | 15,482 | +1.9% | 0.00% | 0.0% |
| Q4 2022 | $5,753,856 | +7.2% | 15,188 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $5,368,000 | +4.9% | 15,203 | +12.5% | 0.00% | 0.0% |
| Q2 2022 | $5,119,000 | +24.8% | 13,511 | +3.8% | 0.00% | +50.0% |
| Q1 2022 | $4,103,000 | +51.8% | 13,012 | +68.6% | 0.00% | +100.0% |
| Q4 2021 | $2,703,000 | +39.0% | 7,718 | +19.9% | 0.00% | 0.0% |
| Q3 2021 | $1,944,000 | +4.2% | 6,439 | +3.9% | 0.00% | 0.0% |
| Q2 2021 | $1,866,000 | -40.8% | 6,197 | -45.9% | 0.00% | -50.0% |
| Q1 2021 | $3,154,000 | +28.6% | 11,452 | +37.3% | 0.00% | 0.0% |
| Q4 2020 | $2,453,000 | +23.1% | 8,342 | +9.9% | 0.00% | 0.0% |
| Q3 2020 | $1,992,000 | +11.4% | 7,589 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $1,788,000 | +70.9% | 7,939 | -0.0% | 0.00% | +100.0% |
| Q1 2020 | $1,046,000 | -9.5% | 7,942 | +10.3% | 0.00% | 0.0% |
| Q4 2019 | $1,156,000 | +130.7% | 7,200 | +63.9% | 0.00% | 0.0% |
| Q3 2019 | $501,000 | -24.0% | 4,394 | -5.5% | 0.00% | 0.0% |
| Q2 2019 | $659,000 | +9.7% | 4,652 | -3.3% | 0.00% | 0.0% |
| Q1 2019 | $601,000 | +24.4% | 4,813 | -4.3% | 0.00% | 0.0% |
| Q4 2018 | $483,000 | – | 5,031 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |